Put Options

11 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2024

May 15, 2024

SELL
$60.67 - $89.12 $1.31 Million - $1.92 Million
-21,600 Reduced 74.23%
7,500 $511,000
Q4 2023

Feb 13, 2024

SELL
$38.62 - $72.18 $1.62 Million - $3.02 Million
-41,900 Reduced 59.01%
29,100 $1.82 Million
Q3 2023

May 14, 2024

BUY
$45.39 - $59.0 $1.9 Million - $2.47 Million
41,900 Added 143.99%
71,000 $3.22 Million
Q1 2023

May 14, 2024

SELL
$41.0 - $56.12 $3.92 Million - $5.37 Million
-95,700 Reduced 57.41%
71,000 $3.21 Million
Q1 2023

May 11, 2023

SELL
$41.0 - $56.12 $3.92 Million - $5.37 Million
-95,700 Reduced 57.41%
71,000 $3.21 Million
Q4 2022

May 14, 2024

SELL
$39.19 - $65.67 $6.34 Million - $10.6 Million
-161,800 Reduced 49.25%
166,700 $6.78 Million
Q4 2022

Feb 13, 2023

SELL
$39.19 - $65.67 $6.34 Million - $10.6 Million
-161,800 Reduced 49.25%
166,700 $6.78 Million
Q3 2022

May 14, 2024

BUY
$61.1 - $83.78 $11.3 Million - $15.5 Million
185,000 Added 128.92%
328,500 $21.5 Million
Q3 2022

Nov 10, 2022

BUY
$61.1 - $83.78 $11.3 Million - $15.5 Million
185,000 Added 128.92%
328,500 $21.5 Million
Q2 2022

May 14, 2024

BUY
$43.23 - $73.83 $4.95 Million - $8.45 Million
114,400 Added 393.13%
143,500 $8.72 Million
Q2 2022

Aug 15, 2022

BUY
$43.23 - $73.83 $6.2 Million - $10.6 Million
143,500 New
143,500 $8.72 Million

Others Institutions Holding CRSP

About CRISPR Therapeutics AG


  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $3.18B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.